Andrew Sfekas
Andrew Sfekas
Unknown affiliation
Verified email at sfekas.com
TitleCited byYear
The impact of workplace smoking bans: results from a national survey
MC Farrelly, WN Evans, AES Sfekas
Tobacco Control 8 (3), 272-277, 1999
3361999
Start spreading the news: a structural estimate of the effects of New York hospital report cards
D Dranove, A Sfekas
Journal of health economics 27 (5), 1201-1207, 2008
1282008
Smoking initiation and the iron law of demand
DR Lillard, E Molloy, A Sfekas
Journal of health economics 32 (1), 114-127, 2013
482013
Does major illness cause financial catastrophe?
K Cook, D Dranove, A Sfekas
Health Services Research 45 (2), 418-436, 2010
462010
How much do physician-entrepreneurs contribute to new medical devices?
SW Smith, A Sfekas
Medical care, 461-467, 2013
262013
Learning, forgetting, and hospital quality: an empirical analysis of cardiac procedures in Maryland and Arizona
A Sfekas
Health economics 18 (6), 697-711, 2009
202009
Does the market punish aggressive experts? Evidence from cesarean sections
D Dranove, S Ramanarayanan, A Sfekas
The BE Journal of Economic Analysis & Policy 11 (2), 2011
182011
Determinants of pharmaceutical sales representative access limits to physicians
GA Chressanthis, A Sfekas, P Khedkar, N Jain, P Poddar
Journal of Medical Marketing 14 (4), 220-243, 2014
162014
Just passing through: the effect of the Master Settlement Agreement on estimated cigarette tax price pass-through
DR Lillard, A Sfekas
Applied economics letters 20 (4), 353-357, 2013
112013
Boundedly rational bargaining in option demand markets: An empirical application
D Dranove, M Satterthwaite, A Sfekas
iHEA 2007 6th World Congress: Explorations in Health Economics Paper, 2007
112007
The revolution in health care antitrust: new methods and provocative implications
D Dranove, A Sfekas
The Milbank Quarterly 87 (3), 607-632, 2009
102009
Anticipating ovarian tissue cryopreservation in the health-care marketplace: a willingness to pay assessment
SL Gardino, A Sfekas, D Dranove
Oncofertility, 363-370, 2010
62010
Do firms use coupons and in-store discounts to strategically market experience goods over the consumption life-cycle? The case of cigarettes
A Sfekas, DR Lillard
National Bureau of Economic Research, 2013
42013
A longitudinal analysis of blockbuster pharmaceutical drugs
T Hannigan, R Mudambi, A Sfekas
DRUID Academy, 2013
42013
Bargaining and leverage in option demand markets
D Dranove, M Satterthwaite, A Sfekas
Unpublished Working Paper. Available at http://kelley. iu. edu/BEPPS, 2011
42011
Coupons and advertising in markets for addictive goods: do cigarette manufacturers react to known future tax increases?
DR Lillard, A Sfekas
Substance Use: Individual Behaviour, Social Interactions, Markets and …, 2005
32005
Quality competition and intra-system substitution in the hospital industry
A Sfekas
American Journal of Health Economics 5 (1), 65-96, 2019
22019
An offer you can’t refuse: Who uses cigarette price discounts?
DR Lillard, A Sfekas
Department of Policy Analysis and Management, Cornell University, working paper, 2010
22010
IS THERE A MEDICAID PENALTY? THE EFFECT OF HOSPITALS'MEDICAID POPULATION ON THEIR PRIVATE PAYER MARKET SHARE
A Sfekas
Health economics 22 (11), 1360-1376, 2013
12013
Focus, Uncertain Needs, and Consumer Choice in the Hospital Industry
A Sfekas
Manufacturing & Service Operations Management, 2019
2019
The system can't perform the operation now. Try again later.
Articles 1–20